Saitama, Japan

Gen'ichi Izu

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Nippon Kayaku Kabushiki Kaisha. Active years: 1997.


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gen'ichi Izu: Innovator in Etoposide Preparations

Introduction

Gen'ichi Izu is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on etoposide preparations. His expertise and dedication to research have led to the development of a unique formulation that enhances the efficacy of etoposide.

Latest Patents

Gen'ichi Izu holds 1 patent related to etoposide preparations. This invention pertains to an etoposide preparation that includes an etoposide composition comprising etoposide, polyvinylpyrrolidone, and a water-soluble cellulose ether derivative. The specific proportions of these components are crucial, with polyvinylpyrrolidone being present in about 0.25 to 2 parts by weight and the water-soluble cellulose ether derivative in about 0.0028 to 0.2 parts by weight per 1 part by weight of etoposide. The etoposide content in the overall composition ranges from 10 to 20% (w/w).

Career Highlights

Throughout his career, Gen'ichi Izu has worked with prominent companies in the pharmaceutical industry, including Nippon Kayaku Kabushiki Kaisha and Minoru Nakada. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug formulations.

Collaborations

Gen'ichi has collaborated with esteemed colleagues such as Yuichi Yazawa and Takashi Terada. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Gen'ichi Izu's contributions to etoposide preparations exemplify his commitment to advancing pharmaceutical science. His innovative formulations have the potential to improve treatment outcomes for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…